The carcinoid syndrome, associated with carcinoid tumors of the midgut, consists of symptoms such as diarrhea, flushing, wheezing and cardiovascular symptoms. This review focuses on these symptoms and discusses therapeutic options. The symptoms are caused by the secretion of biogenic amines, polypeptides and other factors of which serotonin is the most prominent. However, diarrhea is also due to factors such as malabsorption. Besides antitumor therapy, more specific interventions such as serotonin receptor blockers can be useful. The carcinoid heart disease involves the tricuspid and pulmonary valve. In the pathogenesis, serotonin plays a central role. The therapeutic approach is mostly symptomatic. Other cardiovascular complications includ...
Carcinoid heart disease is a complication of a rare syndrome caused by systemic spread of vaso-activ...
Carcinoid syndrome (CS) is a debilitating disease caused by functional neuroendocrine tumors. Severa...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...
The carcinoid syndrome, associated with carcinoid tumors of the midgut, consists of symptoms such as...
Carcinoid tumors are relatively rare neuroendocrine ma-lignancies most commonly originating from ent...
General introduction Carcinoids are rare slowly growing, neuroendocrine tumors. In 1907 Obendorfer w...
Carcinoid tumors are part of a heterogeneous group of gastrointestinal and pancreatic endocrine tumo...
Diarrhea is often the revealing symptom in patients suffering from carcinoid syndrome secondary to a...
Carcinoid syndrome (CS) develops in patients with hormone-producing neuroendocrine neoplasms (NENs) ...
Approximately 30-40% of patients with well-differentiated neuroendocrine tumors present with carcino...
invitation of the Clinical Sciences Review Committee of the Association of Clinical Biochemists. Car...
Carcinoid tumors are the most frequent gut neuroendocrine tumors accounting for more than 50% of all...
This review covers the incidence, prognosis, diagnosis and treatment of midgut carcinoids with empha...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...
Carcinoid heart disease is a complication of a rare syndrome caused by systemic spread of vaso-activ...
Carcinoid syndrome (CS) is a debilitating disease caused by functional neuroendocrine tumors. Severa...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...
The carcinoid syndrome, associated with carcinoid tumors of the midgut, consists of symptoms such as...
Carcinoid tumors are relatively rare neuroendocrine ma-lignancies most commonly originating from ent...
General introduction Carcinoids are rare slowly growing, neuroendocrine tumors. In 1907 Obendorfer w...
Carcinoid tumors are part of a heterogeneous group of gastrointestinal and pancreatic endocrine tumo...
Diarrhea is often the revealing symptom in patients suffering from carcinoid syndrome secondary to a...
Carcinoid syndrome (CS) develops in patients with hormone-producing neuroendocrine neoplasms (NENs) ...
Approximately 30-40% of patients with well-differentiated neuroendocrine tumors present with carcino...
invitation of the Clinical Sciences Review Committee of the Association of Clinical Biochemists. Car...
Carcinoid tumors are the most frequent gut neuroendocrine tumors accounting for more than 50% of all...
This review covers the incidence, prognosis, diagnosis and treatment of midgut carcinoids with empha...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...
Carcinoid heart disease is a complication of a rare syndrome caused by systemic spread of vaso-activ...
Carcinoid syndrome (CS) is a debilitating disease caused by functional neuroendocrine tumors. Severa...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...